Aspirin/Butalbital/Caffeine

阿司匹林/布他比妥/咖啡因

Report date: 2022/07/27 20:00:29
NME

Base Information

Drug NameAspirin/Butalbital/Caffeine
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsGamma-aminobutyric acid A receptor agonistsAdenosine A1 receptor antagonists +[4] 
TargetsCyclooxygenasesGamma-aminobutyric acid A receptorAdenosine A1 receptor +[4] 
Therapy Area/IndicationsHeadache
Global Approved IndicationsHeadache
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1976/05/04
Country/TerritoryUnited States
CombinationsYes AspirinButalbitalCaffeine
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Plc
Active IndicationsN/A
Inactive IndicationsHeadache

Other Information

ATC CodeN/A
Related LinksN/A